|Bid||171.72 x 1000|
|Ask||171.84 x 1000|
|Day's range||170.38 - 172.17|
|52-week range||133.65 - 173.65|
|Beta (5Y monthly)||0.71|
|PE ratio (TTM)||30.35|
|Earnings date||19 Oct 2021|
|Forward dividend & yield||4.24 (2.52%)|
|Ex-dividend date||24 May 2021|
|1y target est||187.39|
Dr. Shikha Jain, Assistant Professor of Medicine, University of Illinois Chicago, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Oracle (ORCL), and SAP SE (SAP).
J&J (JNJ) and Novartis (NVS) announce Q2 results. FDA delays decisions on JAK inhibitor drugs of Lilly (LLY), AbbVie (ABBV) and Pfizer (PFE) for eczema indication.